340B Drug Pricing Program
HHS Issues Proposed Remedy for Its Unlawful 340B Payment Cuts from 2018 to 2022
Register for June 28 Informational Phone Call for 340B Alliance Members On June 28 at 3 p.m. ET.
AHA 340B Advocacy Alliance Bulletin: June 22, 2023.
Louisiana Gov. John Bel Edwards June 19 signed into law state-level protections developed by the AHA. The Louisiana law prevents drug companies from denying, restricting, prohibiting or interfering with the acquisition or delivery of a 340B drug at a contract pharmacy.
AHA yesterday
AHA urges HRSA to restore policy for 340B hospitals with new outpatient facilities.
Over the past 30 years, the 340B Drug Pricing Program has played an essential role in ensuring health care providers have the necessary resources to provide vital programs and services for underserved patients and communities. Ongoing bipartisan support of the program is critical to ensuring…
The AHA May 25 published a report on the 340B Drug Pricing Program, its history and value to hospitals and patients, and details on 340B contract pharmacy arrangements.
AHA, 340B hospitals and stakeholders voice concerns with two pieces of legislation that were recently passed out of the House Energy and Commerce Committee’s Health Subcommittee.
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and…